Life Sciences

IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery

Share this post:

 

Watson Health and Pfizer Inc. today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that uses the body’s immune system to help fight cancer. Pfizer is one of the first organizations worldwide to deploy Watson for Drug Discovery, and the first to customize the cloud-based cognitive tool – tapping into Watson’s machine learning, natural language processing, and other cognitive reasoning technologies to support the identification of new drug targets, combination therapies for study, and patient selection strategies in immuno-oncology.

More Life Sciences stories

No lazy summers for Watson Health: heavy on ‘a’ – action

Written by Watson Health | AI, Blog Post, Life Sciences

Personal values. Commercial pressures. These are forces that shape our jobs every day, especially for leaders in the life sciences. As individuals, we want to solve urgent problems that touch us deeply. As professionals representing growing businesses, we act on our beliefs best when they align with distinct market opportunities. The oft heard slogan of ...read more


Health Quest Medical Practice – Near real-time data

Written by Watson Health | Value-Based Care, Video

Health Quest Medical Practice uses Watson Health solutions to supplement the information in their EHR. Learn how access to enhanced data has helped close patient care gaps and track quality measures. ...read more


Health Quest Medical Practice – Enhancing patient care

Written by Watson Health | Value-Based Care, Video

Hear members of the Health Quest Medical Practice team explain how access to reliable data is a win for both healthcare providers and patients. ...read more